IT1255485B - Processo per preparare gli acidi biliari coniugati con la glicina e relative composizioni terapeutiche per il trattamento dell'insufficienza epatica - Google Patents

Processo per preparare gli acidi biliari coniugati con la glicina e relative composizioni terapeutiche per il trattamento dell'insufficienza epatica

Info

Publication number
IT1255485B
IT1255485B ITMI921924A ITMI921924A IT1255485B IT 1255485 B IT1255485 B IT 1255485B IT MI921924 A ITMI921924 A IT MI921924A IT MI921924 A ITMI921924 A IT MI921924A IT 1255485 B IT1255485 B IT 1255485B
Authority
IT
Italy
Prior art keywords
acid
treatment
therapeutic compositions
related therapeutic
hepatic insufficiency
Prior art date
Application number
ITMI921924A
Other languages
English (en)
Inventor
Antonio Bonaldi
Egidio Molinari
Original Assignee
Erregierre Ind Chim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erregierre Ind Chim filed Critical Erregierre Ind Chim
Priority to ITMI921924A priority Critical patent/IT1255485B/it
Publication of ITMI921924A0 publication Critical patent/ITMI921924A0/it
Priority to CA002092218A priority patent/CA2092218A1/en
Priority to JP5067941A priority patent/JPH0687883A/ja
Priority to EP93109377A priority patent/EP0583566B1/en
Priority to DE69321177T priority patent/DE69321177D1/de
Priority to AT93109377T priority patent/ATE171458T1/de
Publication of ITMI921924A1 publication Critical patent/ITMI921924A1/it
Priority to US08/468,665 priority patent/US5616741A/en
Application granted granted Critical
Publication of IT1255485B publication Critical patent/IT1255485B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Processo per preparare gli acidi biliari coniugati con glicina di formula generale (I): Y - NH - CH 2- COOH (I) dove Y è l'acile di un acido biliare scelto tra: acido chenodesossicolico, acido litocolico, 3?-7?-12?-tri-idrossicolanico. 3?,-7?-diidrossi-12-cheto-colanico, acido desossicolico, acido deidrocolico, acido iodesossicolico, acido iocolico e relative composizioni terapeutiche per il trattamento della insufficienza epatica che li contengono come principi attivi, in combinazione con adatti eccipienti e/o diluenti.
ITMI921924A 1992-08-04 1992-08-04 Processo per preparare gli acidi biliari coniugati con la glicina e relative composizioni terapeutiche per il trattamento dell'insufficienza epatica IT1255485B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ITMI921924A IT1255485B (it) 1992-08-04 1992-08-04 Processo per preparare gli acidi biliari coniugati con la glicina e relative composizioni terapeutiche per il trattamento dell'insufficienza epatica
CA002092218A CA2092218A1 (en) 1992-08-04 1993-03-23 Process for the preparation of glycine-conjugated bile acids and relative pharmaceutical compositions useful for treating hepatic insufficiency
JP5067941A JPH0687883A (ja) 1992-08-04 1993-03-26 グリシン−抱合胆汁酸の製造法及び肝臓機能不全を処置するのに有用な相対的医薬組成物
EP93109377A EP0583566B1 (en) 1992-08-04 1993-06-11 Process for the preparation of glycine-conjugated bile acids
DE69321177T DE69321177D1 (de) 1992-08-04 1993-06-11 Verfahren zur Herstellung Glycin-konjugierter Gallensäure
AT93109377T ATE171458T1 (de) 1992-08-04 1993-06-11 Verfahren zur herstellung glycin-konjugierter gallensäure
US08/468,665 US5616741A (en) 1992-08-04 1995-06-06 Process for the preparation of glycine-conjugated bile acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921924A IT1255485B (it) 1992-08-04 1992-08-04 Processo per preparare gli acidi biliari coniugati con la glicina e relative composizioni terapeutiche per il trattamento dell'insufficienza epatica

Publications (3)

Publication Number Publication Date
ITMI921924A0 ITMI921924A0 (it) 1992-08-04
ITMI921924A1 ITMI921924A1 (it) 1994-02-04
IT1255485B true IT1255485B (it) 1995-11-06

Family

ID=11363833

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921924A IT1255485B (it) 1992-08-04 1992-08-04 Processo per preparare gli acidi biliari coniugati con la glicina e relative composizioni terapeutiche per il trattamento dell'insufficienza epatica

Country Status (6)

Country Link
EP (1) EP0583566B1 (it)
JP (1) JPH0687883A (it)
AT (1) ATE171458T1 (it)
CA (1) CA2092218A1 (it)
DE (1) DE69321177D1 (it)
IT (1) IT1255485B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201703717SA (en) 2014-11-06 2017-06-29 Enanta Pharm Inc Bile acid analogs an fxr/tgr5 agonists and methods of use thereof
WO2016086115A1 (en) 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
MX2017006833A (es) 2014-11-26 2018-02-13 Enanta Pharm Inc Análogos de ácido biliar como agonistas de fxr/tgr5 y métodos para el uso de los mismos.
US10208081B2 (en) 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
RU2017130466A (ru) 2015-02-11 2019-03-12 Энанта Фармасьютикалс, Инк. Аналоги желчной кислоты в качестве агонистов fxr/tgr5 и способы их применения
RS62110B1 (sr) 2015-03-31 2021-08-31 Enanta Pharm Inc Derivati žučnih kiselina kao agonisti fxr/tgr5 i postupci njihove upotrebe
US10323061B2 (en) 2016-02-23 2019-06-18 Enanta Pharmaceuticals, Inc. Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof
US10364267B2 (en) 2016-02-23 2019-07-30 Enanta Pharmaceuticals, Inc. Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
WO2017147137A1 (en) * 2016-02-23 2017-08-31 Enanta Pharmaceuticals, Inc. Benzoic acid derivatives of bile acid as fxr/tgr5 agonists and methods of use thereof
ES2918698T3 (es) 2016-11-29 2022-07-19 Enanta Pharm Inc Proceso para la preparación de derivados del ácido biliar de las sulfonilureas
US10472386B2 (en) 2017-02-14 2019-11-12 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR agonists and methods of use thereof
WO2018187804A1 (en) 2017-04-07 2018-10-11 Enanta Pharmaceuticals, Inc. Process for preparation of sulfonyl carbamate bile acid derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826360B2 (ja) * 1974-08-23 1983-06-02 エ−ザイ カブシキガイシヤ グリコケノデオキシコ−ルサンノ セイホウ
CA1173823A (en) * 1980-08-26 1984-09-04 Leonard M. Hjelmeland Nondenaturing zwitterionic detergent for membrane biochemistry
JPS5826360A (ja) * 1981-08-11 1983-02-16 Sony Corp カセツトロ−デイング機構
IT1152801B (it) * 1982-08-17 1987-01-14 Proter Spa Composti steroidei ad attivita' coleretica, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo
IT1230796B (it) * 1989-05-30 1991-10-29 Prodotti Chimici Alimentari Procedimento per la preparazione di acido tauroursodesossicolico biidrato.

Also Published As

Publication number Publication date
CA2092218A1 (en) 1994-02-05
JPH0687883A (ja) 1994-03-29
EP0583566A2 (en) 1994-02-23
DE69321177D1 (de) 1998-10-29
ITMI921924A1 (it) 1994-02-04
ITMI921924A0 (it) 1992-08-04
EP0583566B1 (en) 1998-09-23
EP0583566A3 (en) 1995-12-27
ATE171458T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
IT1255485B (it) Processo per preparare gli acidi biliari coniugati con la glicina e relative composizioni terapeutiche per il trattamento dell'insufficienza epatica
BR9916746A (pt) Compostos anti-inflamatórios que inibem adesão de célula
IT1264987B1 (it) Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
CH692199A8 (fr) Composes pyridiques et compositions pharmaceutique
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
IT1255486B (it) Processo per preparare gli acidi biliari coniugati con la taurina
ES2066140T3 (es) Derivados de acidos 7-ceto- y 7-hidroxi-androsta-3,5-dieno-3-carboxilicos.
IT8722343A0 (it) Derivati di acidi biliari loro preparazione e composizioni farmaceutiche che li contengono.
YU65995A (sh) Inhibitori 5-lipoksigenaze i njihove farmaceutske kompozicije
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
IE43278L (en) Diphenyl sulfides.
IT1190163B (it) Derivati fosforilalcanolammidici della l-carnitina e composizioni farmaceutiche che li contengono
AR240931A2 (es) Un procedimiento para la preparacion de derivados de silibinina"
ITMI921602A0 (it) Uso di acidi biliari come agenti antivirali
IT1209644B (it) Composti farmacologicamente attivi.
IT1210874B (it) Sale di magnesio dell'acido chenodesossicolico e dell'acido ursodesossicolico, processo per lasua preparazione e composizioni terapeutiche che lo contengono come principio attivo.
GB1344663A (en) Isoindoline compounds
ES2153124T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
ITMI921645A0 (it) Processo per preparare gli acidi biliari coniugati con la glicina e relative composizioni terapeutiche per il trattamento dell'insufficienza epatica
EP0654035A1 (en) PHOSPHONOACETIC ACID AND ESTER AS ANTI-IGNITANT.
IT1274021B (it) Diesteri dell'acido carbonico ad attivita' antivirale ed antinfiammatoria
ITMI911017A1 (it) Nitrosocarbamoil derivati di acidi gem-difosfonici, un processo per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI930420A0 (it) Nuovi derivati di acidi biliari procedimento per la loro preparazione composizioni farmaceutiche che li contengono
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
DE69820301D1 (de) Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäure guaiacyl ester (med 15)

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970828